Arcutis Biotherapeutics's total assets for Q2 2025 were $352.43M, an increase of 2.42% from the previous quarter. ARQT total liabilities were $213.46M for the fiscal quarter, a 5.96% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.